News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provectus Biopharmaceuticals Inc. To Commence Series Of Quarterly Conference Calls On Thursday, August 7, 2014



8/6/2014 9:18:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, will begin a series of regular quarterly conference calls to update the market in general and shareholders in particular about developments at the Company. In the future, these calls will coincide with the filing of the Company’s 10-Q and 10-K filings with the Securities and Exchange Commission as appropriate.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES